- WORLD EDITIONAustraliaNorth AmericaWorld
More Press Releases
Oct 07, 2025
5 Small-cap Biotech ETFs to Watch in 2025
Aug 28, 2025
How to Invest in Gene Stocks and ETFs
More Featured Articles and Inverviews
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Latest News
Latest News
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES